Top Markets
Coin of the day
Tectonic Therapeutic, Inc. Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

TECX
Classifica tra le azioni #11671
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm... Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Prezzo delle azioni
$35.63
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$672.28M
Variazione (1 giorno)
-2.92%
Variazione (1 anno)
39.50%
Paese
US
Scambia Tectonic Therapeutic, Inc. (TECX)

Categoria

Storico del prezzo dell'azione per Tectonic Therapeutic, Inc. (TECX)
Prezzo di chiusura più alto: $35.01 il 2026-08-01

Prezzo di chiusura più basso: $360.74 il 2018-06-01
Storico del prezzo dell'azione di Tectonic Therapeutic, Inc. dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 24.56%
2025 -58.38%
2024 195.42%
2023 72.46%
2022 -79.14%
2021 -73.01%
2020 -28.18%
2019 -9.11%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH